Page last updated: 2024-09-04

ertapenem and Tuberculosis, Drug-Resistant

ertapenem has been researched along with Tuberculosis, Drug-Resistant in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	4 (80.00)	24.3611
2020's	1 (20.00)	2.80

Authors

Authors	Studies
Drobniewski, F; Gonzalo, X; McHugh, TD; Ortiz Canseco, J; Satta, G	1
Alffenaar, JC; Gumbo, T; Srivastava, S; van Rijn, SP; van Soolingen, D; Wessels, MA	1
Alffenaar, JW; Centis, R; D'Ambrosio, L; De Lorenzo, S; Migliori, GB; Sotgiu, G; Tiberi, S; Viggiani, P	1
Akkerman, OW; Alffenaar, JW; de Lange, WC; Kosterink, JG; van Altena, R; van der Laan, T; van der Werf, TS; van Rijn, SP; van Soolingen, D	1
Centis, R; D'Ambrosio, L; Dore, S; Esposito, S; Migliori, GB; Sotgiu, G; Spanevello, A; Tiberi, S	1

Reviews

1 review(s) available for ertapenem and Tuberculosis, Drug-Resistant

Article	Year
Carbapenems to Treat Multidrug and Extensively Drug-Resistant Tuberculosis: A Systematic Review. International journal of molecular sciences, 2016, Mar-12, Volume: 17, Issue:3 Topics: Antitubercular Agents; beta-Lactams; Carbapenems; Clinical Studies as Topic; Ertapenem; Extensively Drug-Resistant Tuberculosis; Humans; Imipenem; Meropenem; Thienamycins; Treatment Outcome; Tuberculosis, Multidrug-Resistant	2016

Article

Year

Carbapenems to Treat Multidrug and Extensively Drug-Resistant Tuberculosis: A Systematic Review.

International journal of molecular sciences, 2016, Mar-12, Volume: 17, Issue:3

Topics: Antitubercular Agents; beta-Lactams; Carbapenems; Clinical Studies as Topic; Ertapenem; Extensively Drug-Resistant Tuberculosis; Humans; Imipenem; Meropenem; Thienamycins; Treatment Outcome; Tuberculosis, Multidrug-Resistant

2016

Other Studies

4 other study(ies) available for ertapenem and Tuberculosis, Drug-Resistant

Article	Year
Ertapenem and Faropenem against Mycobacterium tuberculosis: in vitro testing and comparison by macro and microdilution. BMC microbiology, 2020, 08-31, Volume: 20, Issue:1 Topics: Amoxicillin-Potassium Clavulanate Combination; Antitubercular Agents; beta-Lactams; Drug Resistance, Bacterial; Ertapenem; Humans; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Tuberculosis; Tuberculosis, Multidrug-Resistant	2020
Sterilizing Effect of Ertapenem-Clavulanate in a Hollow-Fiber Model of Tuberculosis and Implications on Clinical Dosing. Antimicrobial agents and chemotherapy, 2017, Volume: 61, Issue:9 Topics: Antitubercular Agents; beta-Lactams; Clavulanic Acid; Computer Simulation; Dose-Response Relationship, Drug; Drug Therapy, Combination; Ertapenem; Humans; Microbial Sensitivity Tests; Monte Carlo Method; Mycobacterium tuberculosis; Tuberculosis, Multidrug-Resistant	2017
Ertapenem in the treatment of multidrug-resistant tuberculosis: first clinical experience. The European respiratory journal, 2016, Volume: 47, Issue:1 Topics: Adult; Anti-Bacterial Agents; Antitubercular Agents; beta-Lactams; Drug Therapy, Combination; Ertapenem; Extensively Drug-Resistant Tuberculosis; Female; Humans; Male; Middle Aged; Retrospective Studies; Tuberculosis, Multidrug-Resistant; Young Adult	2016
Pharmacokinetics of ertapenem in patients with multidrug-resistant tuberculosis. The European respiratory journal, 2016, Volume: 47, Issue:4 Topics: Adolescent; Adult; Aged; Antitubercular Agents; Area Under Curve; beta-Lactams; Ertapenem; Extensively Drug-Resistant Tuberculosis; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Netherlands; Retrospective Studies; Tuberculosis, Multidrug-Resistant; Young Adult	2016